SHENZHEN, China, Dec. 10, 2023 /PRNewswire/ — On December 10, VAPORESSO, a leading brand in the vaping industry, has officially launched its new initiative, the 2023 VAPORESSO CARE ECO GO GREEN – Global Carbon Neutral Program (“the Program“). This Program, slated to continue until July 2024, is the first carbon-neutral green practice in the vaping… Continue reading 2023 VAPORESSO CARE ECO GO GREEN – Global Carbon Neutral Program Kicked Off
Category: Newswire
Global Incubation Innovation Forces Gather in Lingang for World Top-Performing Incubator Forum 2023
SHANGHAI, Dec. 9, 2023 /PRNewswire/ — From December 5th to 6th, World Top-Performing Incubator Forum 2023 with the theme of “Innovation Incubates the Future” was held in Lingang New Area. Chen Jinshan, member of the Standing Committee of the CPC Shanghai Municipal Committee, Secretary of Party Working Committee of Lingang New Area, Director of Lingang Special… Continue reading Global Incubation Innovation Forces Gather in Lingang for World Top-Performing Incubator Forum 2023
Pudgy Penguins Announces Pudgy World Alpha Powered by zkSync at Art Basel Miami
The interactive experience will include the introduction of two “Hero Characters,” new story-driven missions, quests, and an open-world to explore. LOS ANGELES, Dec. 9, 2023 /PRNewswire/ — Pudgy Penguins, the IP and brand development company behind the series of globally recognized characters and one of the most popular NFT collections, today announced the upcoming alpha… Continue reading Pudgy Penguins Announces Pudgy World Alpha Powered by zkSync at Art Basel Miami
Global Incubation Innovation Forces Gather in Lingang for World Top-Performing Incubator Forum 2023
SHANGHAI, Dec. 9, 2023 /PRNewswire/ — From December 5th to 6th, World Top-Performing Incubator Forum 2023 with the theme of “Innovation Incubates the Future” was held in Lingang New Area. Chen Jinshan, member of the Standing Committee of the CPC Shanghai Municipal Committee, Secretary of Party Working Committee of Lingang New Area, Director of Lingang Special… Continue reading Global Incubation Innovation Forces Gather in Lingang for World Top-Performing Incubator Forum 2023
Studies Uncover Drivers of Health Disparities and Opportunities to Enhance Equity
Research underscores continuing role of demographic factors and comorbidities in blood cancer treatment and research SAN DIEGO, Dec. 9, 2023 /PRNewswire/ — Four studies presented during the 65th American Society of Hematology (ASH) Annual Meeting and Exposition examine how demographics and other characteristics of patients and researchers play into inequities in health outcomes in the… Continue reading Studies Uncover Drivers of Health Disparities and Opportunities to Enhance Equity
Studies Highlight Impacts of Applying New Technologies in Everyday Care
Findings show benefits of AI-driven techniques, chemotherapy-free treatments, and cell therapy SAN DIEGO, Dec. 9, 2023 /PRNewswire/ — Researchers report striking progress in the application of cutting-edge tools and treatments to address longstanding challenges in blood disorders and related health conditions in four studies presented during the 65th American Society of Hematology (ASH) Annual Meeting… Continue reading Studies Highlight Impacts of Applying New Technologies in Everyday Care
Research Reveals Opportunities to Better Address Blood Disorders Early in Life
Studies point to preventive measures and therapies that can set children on a healthier course with lifelong benefits SAN DIEGO, Dec. 9, 2023 /PRNewswire/ — Researchers report significant progress toward improving access to effective interventions to address blood disorders and promote healthy blood cell functioning in four studies presented during the 65th American Society of… Continue reading Research Reveals Opportunities to Better Address Blood Disorders Early in Life
OnlyFans Search Unveiled: Fanscout’s Groundbreaking New Approach
Fanscout.com addresses the limited search capabilities on OnlyFans by offering a unique solution with real customer reviews, significantly enhancing the discovery and connection process for users and creators. LAS VEGAS, Dec. 9, 2023 /PRNewswire/ — The Challenge of Searching on OnlyFans Navigating OnlyFans search can be a daunting task due to its limited search capabilities, often leaving… Continue reading OnlyFans Search Unveiled: Fanscout’s Groundbreaking New Approach
Die Menarini Group präsentiert auf dem SABCS 2023 neue progressionsfreie Überlebensdaten aus der klinischen EMERALD-Studie zu ORSERDU® (Elacestrant) in klinisch relevanten Untergruppen von Patienten mit ER+, HER2- metastasiertem Brustkrebs (Metastatic Breast Cancer, mBC) mit ESR1-Mutationen
Diese neue Post-hoc-Analyse der Phase-3-EMERALD-Studie untersuchte Elacestrant in der endokrin sensitiven Population (CDK4/6-Inhibitor-Dauer von mindestens 12 Monaten) mit Tumoren, die ESR1-Mutationen aufweisen. Diese Analyse weist auf eine klinisch bedeutsame Verbesserung des progressionsfreien Überlebens in allen untersuchten Untergruppen hin, einschließlich der Patienten mit Knochen-, Leber- und/oder Lungenmetastasen, der Patienten mit häufigen Begleitmutationen wie PIK3CA und TP53 sowie der… Continue reading Die Menarini Group präsentiert auf dem SABCS 2023 neue progressionsfreie Überlebensdaten aus der klinischen EMERALD-Studie zu ORSERDU® (Elacestrant) in klinisch relevanten Untergruppen von Patienten mit ER+, HER2- metastasiertem Brustkrebs (Metastatic Breast Cancer, mBC) mit ESR1-Mutationen
Servier Showcases Leadership in Mutant Isocitrate Dehydrogenase (IDH) Inhibition Through New Data Spotlighting Real-World Treatment Patterns and Clinical Outcomes of Tibsovo® Use at ASH 2023
Learn more about Servier’s leadership in mutant IDH inhibition at ASH booth #1347 BOSTON, Dec. 9, 2023 /PRNewswire/ — Servier, a leader in oncology committed to bringing the promise of tomorrow to the patients we serve, will be presenting new data in acute myeloid leukemia (AML) at the 65th American Society of Hematology (ASH) Annual Meeting… Continue reading Servier Showcases Leadership in Mutant Isocitrate Dehydrogenase (IDH) Inhibition Through New Data Spotlighting Real-World Treatment Patterns and Clinical Outcomes of Tibsovo® Use at ASH 2023